MedPath

Healthy Term Infants Fed Milk-Based Formulas

Not Applicable
Terminated
Conditions
Infants
Interventions
Other: Standard Milk-based Formula Containing Carotenoid
Other: Investigational Milk-based Formula Containing Carotenoid
Registration Number
NCT02069522
Lead Sponsor
Abbott Nutrition
Brief Summary

This is a prospective, double blind, crossover study in healthy infants randomized to one of two study formulas. The trial will consist of two 21 day study feeding periods separated by a study washout period.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
91
Inclusion Criteria
  • Infant is in good health
  • Infant is a singleton from a full term birth with a gestational age of 37-42 weeks
  • Infant's birth weight was > 2490 g (~5 lbs 8 oz)
  • Infant is between 14 and 28 days of age
  • Parent(s) confirm intention to feed their infant the study product(s) as the sole source of nutrition for the duration of the study
  • Parent(s) confirm intention not to administer vitamin or mineral supplements, DHA and ARA supplements, solid foods/juices to their infant from enrollment through the duration of the study
Exclusion Criteria
  • An adverse maternal, fetal or infant medical history that has potential for effects on tolerance, growth, and/or development.
  • Infants using medications (including OTC), home remedies, herbal preparations, probiotics or rehydration fluids that might affect gastrointestinal (GI) tolerance

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Standard Milk-based Formula Containing CarotenoidStandard Milk-based Formula Containing Carotenoidmilk-based ready to feed infant formula
Investigational Milk-based Formula Containing CarotenoidInvestigational Milk-based Formula Containing Carotenoidinvestigational milk-based ready to feed infant formula
Primary Outcome Measures
NameTimeMethod
Carotenoid ConcentrationChange from Baseline to end of Study Period A (~21 Days)

Plasma sample

Secondary Outcome Measures
NameTimeMethod
Carotenoid ConcentrationChange from Baseline to end Study Periods A (~21 Days) and B (~21 Days)

Plasma sample

Trial Locations

Locations (6)

Midwest Children's Health Research Institute

🇺🇸

Lincoln, Nebraska, United States

MetroHealth Medical Center

🇺🇸

Cleveland, Ohio, United States

Northpoint Pediatrics

🇺🇸

Indianapolis, Indiana, United States

Institute of Clinical Research

🇺🇸

Mayfield Heights, Ohio, United States

Tuscon Medical Center

🇺🇸

Tuscon, Arizona, United States

Dayton Clinical Research

🇺🇸

Dayton, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath